Ahead of Oct. 29 advisory committee to discuss drug . . .

Public Citizen To FDA: Withdraw Approval Of Makena And Its Generics

By Beth Wang / October 8, 2019 at 3:55 PM
Public Citizen is calling on FDA to withdraw approval of all hydroxyprogesterone caproate-containing drugs, including the brand drug Makena, which are used to reduce risk of preterm birth in women. Postmarket studies that were required as a condition of Makena’s approval have failed to verify the drug provides significant clinical benefit over placebo, and an FDA panel will convene in three weeks to consider the trial’s findings. In a citizen petition filed Tuesday (Oct. 8), Public Citizen calls for FDA...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.